LENSAR (NASDAQ:LNSR) Trading 0.6% Higher – Time to Buy?

LENSAR, Inc. (NASDAQ:LNSR) shares were up 0.6% during trading on Thursday . The company traded as high as $12.66 and last traded at $12.28. Approximately 113,489 shares were traded during mid-day trading, an increase of 262% from the average daily volume of 31,360 shares. The stock had previously closed at $12.21.

Analyst Upgrades and Downgrades

LNSR has been the topic of a number of recent research reports. Wall Street Zen raised LENSAR to a “hold” rating in a research note on Friday, November 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of LENSAR in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $15.00.

LENSAR Trading Up 0.6%

The stock has a market capitalization of $146.68 million, a PE ratio of -2.80 and a beta of 0.69. The stock has a 50 day moving average price of $11.77 and a 200-day moving average price of $11.95.

LENSAR (NASDAQ:LNSR) last posted its earnings results on Thursday, November 6th. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.23). The business had revenue of $14.32 million during the quarter, compared to the consensus estimate of $17.75 million.

Institutional Trading of LENSAR

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets boosted its stake in shares of LENSAR by 129.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company’s stock worth $25,000 after acquiring an additional 1,131 shares during the last quarter. Police & Firemen s Retirement System of New Jersey purchased a new position in LENSAR during the second quarter valued at $34,000. JPMorgan Chase & Co. grew its holdings in LENSAR by 584.3% during the second quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock valued at $62,000 after purchasing an additional 3,991 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in LENSAR in the second quarter worth about $68,000. Finally, New York State Common Retirement Fund purchased a new stake in LENSAR in the second quarter worth about $105,000. 40.15% of the stock is owned by hedge funds and other institutional investors.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.